These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31484540)

  • 1. A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma.
    Liu Y; Bian T; Zhang Y; Zheng Y; Zhang J; Zhou X; Xie J
    Diagn Pathol; 2019 Sep; 14(1):100. PubMed ID: 31484540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
    Shams TM
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.
    Vazquez I; Papaleo N; Lop J; Puiggros A; Sanchez-Gonzalez B; Diez-Feijoo R; Gimeno E; Andrade-Campos M; Salar A; Espinet B; Salido M; Tapia G; Carreras J; Ferrer A; Arenillas L; Calvo X; Colomo L
    Virchows Arch; 2021 Dec; 479(6):1073-1078. PubMed ID: 33811533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
    Alsuwaidan A; Pirruccello E; Jaso J; Koduru P; Garcia R; Krueger J; Doucet M; Chaudhry R; Fuda F; Chen W
    Cytometry B Clin Cytom; 2019 Sep; 96(5):368-374. PubMed ID: 30734478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J
    Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.
    Papaleo N; Climent F; Tapia G; Luizaga L; Azcarate J; Bosch-Schips J; Muñoz-Marmol AM; Salido M; Lome-Maldonado C; Vazquez I; Colomo L
    Virchows Arch; 2024 Aug; 485(2):307-314. PubMed ID: 37368083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
    Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
    Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation.
    Rodig SJ; Vergilio JA; Shahsafaei A; Dorfman DM
    Am J Surg Pathol; 2008 Jan; 32(1):113-22. PubMed ID: 18162778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.
    Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
    Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
    Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
    Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
    Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of HGAL and LMO2 in follicular lymphoma].
    Zhang F; Luo D; Luo X; Chen Y; Xu J; Chen J; Zhuang H; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):83-5. PubMed ID: 26879427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
    Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
    Patel JL; Pournazari P; Haggstrom SJ; Kosari F; Shabani-Rad MT; Natkunam Y; Mansoor A
    Histopathology; 2014 Jan; 64(2):226-33. PubMed ID: 24330148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
    Cerhan JR; Natkunam Y; Morton LM; Maurer MJ; Asmann Y; Habermann TM; Vasef MA; Cozen W; Lynch CF; Allmer C; Slager SL; Lossos IS; Chanock SJ; Rothman N; Hartge P; Dogan A; Wang SS
    Leuk Lymphoma; 2012 Jun; 53(6):1105-12. PubMed ID: 22066713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.